Agilent/Dako

Estrogen Receptor ?

#M7047 · western blot

100
Citing papers
4.6k
Combined citations
Supplier page Find this product

Research areas

Breast Cancer Treatment Studies30Estrogen and related hormone effects25Cancer Cells and Metastasis15HER2/EGFR in Cancer Research12Breast Lesions and Carcinomas10Cancer-related Molecular Pathways10Cancer Risks and Factors9Reproductive System and Pregnancy8

Papers citing this product

1
Epithelial to Mesenchymal Transition in Human Breast Cancer Can Provide a Nonmalignant Stroma
American Journal Of Pathology·2003·310 cit.·DOI
2
Comprehensive omic characterization of breast cancer in Mexican-Hispanic women
Nature Communications·2021·291 cit.·DOI
3
Magnetic Resonance Imaging and Mammography in Women With a Hereditary Risk of Breast Cancer
JNCI Journal of the National Cancer Institute·2001·286 cit.·DOI
4
The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer
Nature Medicine·2021·253 cit.·DOI
5
Insufficient antibody validation challenges oestrogen receptor beta research
Nature Communications·2017·252 cit.·DOI
6
Enhanced Epidermal Growth Factor Receptor Signaling in MCF7 Breast Cancer Cells after Long-Term Culture in the Presence of the Pure Antiestrogen ICI 182,780 (Faslodex)*
Endocrinology·2001·249 cit.·DOI
7
COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ
British Journal of Cancer·2004·198 cit.·DOI
8
RANKL/RANK control Brca1 mutation-driven mammary tumors
Cell Research·2016·173 cit.·DOI
9
Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients
British Journal of Cancer·2004·166 cit.·DOI
10
Long-term outcome in young women with breast cancer: a population-based study
Breast Cancer Research and Treatment·2016·127 cit.·DOI